NCT07595666 Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. Status ENROLLING_BY_INVITATION Phase NA
NCT07584499 Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT07518654 Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07516678 Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma Status RECRUITING Phase N/A
NCT07399821 An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT07261241 NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab Status NOT_YET_RECRUITING Phase PHASE2
NCT07223606 Fecal Microbiota Transplant for Neuroblastoma in a Single Patient Status NO_LONGER_AVAILABLE Phase N/A
NCT07195500 Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma Status RECRUITING Phase N/A
NCT07172958 Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) Status RECRUITING Phase PHASE1
NCT07141862 Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method Status RECRUITING Phase N/A
NCT07111117 Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma. Status NOT_YET_RECRUITING Phase PHASE2
NCT07090538 GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma. Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07067346 Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma Status RECRUITING Phase EARLY_PHASE1
NCT07027748 Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma Status RECRUITING Phase PHASE1
NCT06995872 Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma Status RECRUITING Phase PHASE1
NCT06988475 DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations Status RECRUITING Phase PHASE2/PHASE3
NCT06948994 A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06942039 Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation Status RECRUITING Phase EARLY_PHASE1
NCT06933394 Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma Status RECRUITING Phase PHASE2